Artificial Intelligence in Colonoscopy
Recruiting
N/A
Interventional Study
Quality Indicators, Health Care
Artificial Intelligence (AI)
Colonoscopy Diagnostic Techniques and Procedures
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 630 (estimated)
- Sponsor
- Jagiellonian University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Colorectal cancer is the second most common malignancy in the countries of the European Union. Colonoscopy is the primary method for detecting and preventing the development of colorectal cancer is endoscopic examination. This study aims to evaluate the impact of artificial intelligence on the detection rate of polyps and early stages of colorectal cancer.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Consent to participate in the study,
* Age between 50 and 65 years,
* Scheduled outpatient colonoscopy.
Exclusion Criteria:
* Previous colonoscopy,
* History of colorectal surgery,
* Ongoing biological therapy for any indication,
* Primary sclerosing cholangitis,
* Familial …
Contacts